Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adynovate in pediatric severe hemophilia A
NCT02210091Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2014
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Started Oct 2014; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02210091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02210091.